Journal article
Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotictumor lysate
Abstract
New approaches in the treatment of chronic B lymphocytic leukemia (B-CLL) have led to improved clinical response rates. In this setting there is a need to evaluate novel therapeutic approaches that aim to eradicate minimal residual B-CLL cells following an initial favorable response. The use of tumor lysate-pulsed dendritic cells (DC) represents a potentially important development in the field of cancer vaccination. B-CLL is ideally suited for …
Authors
Suresh K; Fraser G; Scheid E; Leber B; Gauldie J; Foley R
Journal
Leukemia & Lymphoma, Vol. 47, No. 2, pp. 297–306
Publisher
Taylor & Francis
Publication Date
January 2006
DOI
10.1080/10428190500301231
ISSN
1042-8194